The good, the bad and chronic hepatitis
Today is World Hepatitis Day and it brings good news and bad news. The bad news is that hepatitis is still a serious condition which affects nearly 400,000 Australians putting them on a course to serious liver disease. The good news is that treatment is now less invasive, of shorter duration, much more effectiveand diagnosis doesnt involve humongous needles, says Dr Nick Shackel from the Centenary Institute.
With hepatitis C, he says, the problem is that although, you are more likely to die with the virus, not from the virus we still cannot predict those people who will do badly.
His research into the genes that are triggered when hepatitis strikes, should improve things further by allowing better and earlier understanding of the likely course of the disease in individual patients.
Hepatitis is an inflammation of the liver caused by infection with a virus. The virus types B and C that lead to chronic conditions are the most common causes of liver scarring or cirrhosis and liver cancer.
Those diagnosed with the virus usually visit their doctors complaining of extreme tiredness. The disease is picked up through a routine blood test, and they are then referred to a specialist.
In the past, assessment of the severity of the disease involved a biopsyextracting a small piece of liver tissue with a needle. But nowadays, this can be done quickly and painlessly by means of an ultrasound, known as Fibroscan, which probes the livers stiffness, says Dr Shackel, who is also a senior staff specialist at the Royal Prince Alfred Hospital.
Under the latest treatment regimes, Hepatitis C virus can be cleared using drugs from better than 80 per cent of people within six months to a year. And there are new treatments on the horizon which may bring that down to less than 20 weeks, says Dr Shackel.
Hepatitis B is also treated with drugs for at least six months and often over many years. But it demands ongoing management, because once infected, you never get rid of it. While the treatment is effective, says Dr Shackel, I tell my patients, Youll always have the virus but we can control it. Understanding when to start, stop and change treatments in individual patients with hepatitis B is one of the major problems with this disease,
In the laboratory, he is working to change this, searching for protein markers, which can be used to predict the progress of the disease. In future, he hopes, doctors will be able to sort out those patients likely to develop cirrhosis or liver cancer from those whose condition will take a milder course. At that point, therapy can be personalised.
We should be able to provide the minimum treatment for the maximum response. And that will not only provide hepatitis patients with a better quality of life, but also will save money and medical resources.
Dr Shackels commitment to liver research is matched by his University of Sydney PhD student Wil DAvigdor, who is currently somewhere between London and Ulaanbaatar in the 2012 Mongol Rallyrisking life and limb to raise money for liver research at the Institute. At the Centenary Institute he studies the genetics of hepatitis C.
There is currently no vaccine for hepatitis C and it infects up to 300 million people worldwide, including more than 10% of the people of Mongolia.
More information: World Hepatitis Day is organised by the World Hepatitis Alliance, a global voice for the 500 million people worldwide living with chronic viral hepatitis B or C. Follow them at @Hep_Alliance. More information at worldhepatitisalliance.org .
Provided by Science in Public
- New vaccine for hepatitis C virus Jul 28, 2011 | not rated yet | 0
- Pinpointing a tell-tale mark of liver cancer Jul 08, 2011 | not rated yet | 0
- Noninvasive liver tests may predict hepatitis C patient survival Jun 14, 2011 | not rated yet | 0
- Possible hepatitis C vaccine Sep 05, 2007 | not rated yet | 0
- Hepatitis C kills more Americans than HIV: study Feb 23, 2012 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011 I'd like to open a discussion thread for version 2 of the draft of my book ''Classical and Quantum Mechanics via Lie algebras'', available online at http://lanl.arxiv.org/abs/0810.1019 , and for the...
- More from Physics Forums - Independent Research
More news stories
As the world prepares for what may be the next pandemic strain of influenza virus, in the H7N9 bird flu, a new UC Irvine study reveals that the 2009 H1N1 swine flu pandemic was deadliest for people under the age of 65, while ...
Diseases, Conditions, Syndromes 15 hours ago | not rated yet | 0
The World Health Organization says the Horn of Africa is experiencing an outbreak of polio with cases confirmed in Kenya and Somalia.
Diseases, Conditions, Syndromes 16 hours ago | not rated yet | 0
A man who had contracted the coronavirus has died in Saudi Arabia, raising the death toll in the kingdom from the SARS-like virus to 17, the health ministry announced on its website on Wednesday.
Diseases, Conditions, Syndromes 16 hours ago | not rated yet | 0
A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine ...
Diseases, Conditions, Syndromes 16 hours ago | not rated yet | 0 |
Patients with underlying heart failure are more likely to experience adverse outcomes from mild hypothyroidism, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & ...
Diseases, Conditions, Syndromes 18 hours ago | not rated yet | 0
(Medical Xpress)—Researchers at the University of Virginia School of Medicine have identified a promising target for treating glioblastoma, one that appears to avoid many of the obstacles that typically frustrate efforts ...
55 minutes ago | not rated yet | 0 |
(Medical Xpress)—The first symptoms of major depression may be behavioral, but the common mental illness is based in biology—and not limited to the brain.
49 minutes ago | 5 / 5 (1) | 0 |
(Medical Xpress)—Scientists at Emory Vaccine Center have shown that an immune regulatory molecule called IL-21 is needed for long-lasting antibody responses in mice against viral infections.
43 minutes ago | not rated yet | 0 |
As health services strive to improve quality and reduce costs, researchers study the benefits – and the pitfalls – of 'pay for performance' in hospitals.
4 seconds ago | not rated yet | 0 |
Human breastmilk responds quickly to protect the child when there is an infection in mothers or babies, according to new international research led by The University of Western Australia.
55 minutes ago | not rated yet | 0
(Medical Xpress)—According to the World Health Organization, approximately 70 million couples experience infertility worldwide. Current data suggests that nearly one third of infertility disorders are due ...
10 minutes ago | not rated yet | 0